Monthly Archives: April 2021

High-cost claims and injectable drug trends analysis

Sunlife | High Cost Claims and Injectables Trend report Sunlife produces this annual report....  Nothing earth shattering here but its good info and can be used as a benchmark to measure our own performance against.

2021-04-26T14:30:23+00:00April 26th, 2021|Industry News|Comments Off on High-cost claims and injectable drug trends analysis

Davita and Fresenius….a Monopoly?

Dialysis is big business!  For those in the know, the market is dominated by two entities:  Davita and Fresenius, and they continue to expand their stranglehold on the market.  Makes you wonder at what point does this monopoly get recognized by big brother? Freakonomics did a great job (as usual) summarizing the market and highlighting [...]

2021-04-22T13:35:54+00:00April 22nd, 2021|Cost Containment|Comments Off on Davita and Fresenius….a Monopoly?

Milliman Whitepaper on Direct Primary Care Models

4-5-21-Milliman - Direct-Primary-Care - Actuarial Study This is a a worthwhile read to remind us of the key considerations of these models, and to help align our expectations of their potential, in both improvements in quality of care, and potential savings/cost increases of Direct Primary Care models.  A more comprehensive, detailed study would have been [...]

2021-04-22T13:07:47+00:00April 22nd, 2021|Direct Primary Care|Comments Off on Milliman Whitepaper on Direct Primary Care Models
Go to Top